Form FWP Morgan Stanley Finance Filed by: Morgan Stanley Finance LLC
Tweet
Share
E-mail
Morgan Stanley Finance LLC Structured Investments |
Free Writing Prospectus |
| Filed pursuant to Rule 433 | |
| Registration Statement Nos. 333-250103; 333-250103-01 | |
| December 1, 2021 |
Market Linked Securities—Leveraged Upside Participation and Contingent Downside Principal at Risk Securities Linked to the Lowest Performing of the EURO STOXX 50® Index and the STOXX® Europe 600 Index due January 6, 2027 Fully and Unconditionally Guaranteed by Morgan Stanley |
Summary of terms
| Issuer | Morgan Stanley Finance LLC |
| Guarantor | Morgan Stanley |
| Term | Approximately 5 years |
| Underlyings | EURO STOXX 50® Index (the “SX5E Index”) and STOXX® Europe 600 Index (the “SXXP Index”) |
| Pricing date | December 29, 2021* |
| Original issue date | January 3, 2022* |
| Face amount | $1,000 per security (100% of par) |
| Maturity payment amount | See “Investment description” on this page and “How the maturity payment amount is calculated” on page 4. |
| Maturity date | January 6, 2027* |
| Starting level | With respect to each underlying, its closing level on the pricing date |
| Ending level | With respect to each underlying, its closing level on the calculation day |
| Threshold level | 75% of the starting level for each underlying |
| Participation rate | 265% to 285%, to be determined on the pricing date |
| Lowest performing underlying | The underlying with the lowest underlying return |
| Underlying return |
With respect to an underlying, the percentage change from its starting level to its ending level, measured as follows: ending level – starting level starting level |
| Calculation day | December 29, 2026* |
| Calculation agent | Morgan Stanley & Co. LLC, an affiliate of the issuer and the guarantor |
| Denominations | $1,000 and any integral multiple of $1,000 |
| Agent discount |
Morgan Stanley & Co. LLC and Wells Fargo Securities, LLC will act as the agents for this offering. Wells Fargo Securities, LLC will receive a commission of up to $36.20 for each security it sells. Dealers, including Wells Fargo Advisors (“WFA”), may receive a selling concession of up to $25 per security, and WFA will receive a distribution expense fee of $1.20 for each security sold by WFA. In respect of certain securities sold in this offering, we may pay a fee of up to $1.50 per security to selected securities dealers in consideration for marketing and other services in connection with the distribution of the securities to other securities dealers. |
| CUSIP | 61773FH89 |
Investment description
| · | Linked to the lowest performing of the EURO STOXX 50® Index and the STOXX® Europe 600 Index (each referred to as an “underlying”) |
| · | Unlike ordinary debt securities, the securities do not pay interest or repay a fixed amount of the face amount at maturity. Instead, the securities provide for a maturity payment amount that may be significantly less than the face amount, and may be zero. |
At maturity, the maturity payment amount per $1,000 face amount of securities will be determined as follows:
| o | If the level of the lowest performing underlying increases: |
You will receive the face amount plus a positive return equal to 265% to 285% (to be determined on the pricing date) of the percentage increase in the level of the lowest performing underlying from its starting level.
| o | If the level of the lowest performing underlying decreases, but the decrease is not more than 25%: |
You will receive the face amount.
| o | If the level of the lowest performing underlying decreases by more than 25%: |
You will have full downside exposure to the decrease in the level of the lowest performing underlying from its starting level, and you will lose more than 25%, and possibly all, of the face amount
| · | Investors may lose a significant portion, or all, of the face amount of the securities. |
| · | All payments are subject to our credit risk. If we default on our obligations, you could lose some or all of your investment. These securities are not secured obligations and you will not have any security interest in, or otherwise have any access to, any securities included in either of the underlyings. |
| · | No periodic interest payments or dividends. |
| · | No exchange listing; designed to be held to maturity. |
*To the extent the issuer makes any change to the pricing date or original issue date, the calculation day and maturity date may also be changed in the issuer’s discretion to ensure that the term of the securities remains the same.
The face amount of each security is $1,000. This price includes costs associated with issuing, selling, structuring and hedging the securities, which are borne by you, and, consequently, the estimated value of the securities on the pricing date will be less than $1,000 per security. We estimate that the value of each security on the pricing date will be approximately $941.80, or within $41.80 of that estimate. Our estimate of the value of the securities as determined on the pricing date will be set forth in the final pricing supplement. See “Investment Summary” and “Risk Factors” in the accompanying preliminary terms for further information.
The securities have complex features and investing in the securities involves risks not associated with an investment in ordinary debt securities. See “Risk Factors” in the accompanying preliminary terms. All payments on the securities are subject to our credit risk.
This introductory term sheet does not provide all of the information that an investor should consider prior to making an investment decision.
Investors should carefully review the accompanying preliminary terms, product supplement for PLUS, index supplement and prospectus before making a decision to invest in the securities.
The securities are not deposits or savings accounts and are not insured by the Federal Deposit Insurance Corporation or any other governmental agency or instrumentality, nor are they obligations of, or guaranteed by, a bank.
|
Hypothetical payoff diagram
The payoff diagram to the right reflects a range of hypothetical underlying returns of the lowest performing underlying and is based on the hypothetical participation rate of 265% and the threshold level of 75% of the starting level for each underlying.
This diagram has been prepared for purposes of illustration only. Your actual return will depend on the actual ending levels of the underlyings and participation rate and whether you hold your securities to maturity.
|
 |
Hypothetical returns
The hypothetical return table below is based on the hypothetical participation rate of 265%, the threshold level of 75% of the starting level for each underlying and a hypothetical starting level of 100 for each underlying. The following examples are for illustrative purposes only. The actual starting levels, threshold levels and participation rate will be determined on the pricing date.
|
Performance of the Lowest Performing Underlying* |
Performance of the Securities(1) |
||
|
Ending Level |
Underlying Return |
Maturity Payment Amount |
Return on Securities(2) |
| 200 | 100.00% | $3,650.00 | 265.00% |
| 190 | 90.00% | $3,385.00 | 238.50% |
| 180 | 80.00% | $3,120.00 | 212.00% |
| 170 | 70.00% | $2,855.00 | 185.50% |
| 160 | 60.00% | $2,590.00 | 159.00% |
| 150 | 50.00% | $2,325.00 | 132.50% |
| 140 | 40.00% | $2,060.00 | 106.00% |
| 130 | 30.00% | $1,795.00 | 79.50% |
| 120 | 20.00% | $1,530.00 | 53.00% |
| 110 | 10.00% | $1,265.00 | 26.50% |
| 105 | 5.00% | $1,132.50 | 13.25% |
| 100(3) | 0.00% | $1,000.00 | 0.00% |
| 95 | -5.00% | $1,000.00 | 0.00% |
| 90 | -10.00% | $1,000.00 | 0.00% |
| 80 | -20.00% | $1,000.00 | 0.00% |
| 75 | -25.00% | $1,000.00 | 0.00% |
| 74 | -26.00% | $740.00 | -26.00% |
| 70 | -30.00% | $700.00 | -30.00% |
| 60 | -40.00% | $600.00 | -40.00% |
| 50 | -50.00% | $500.00 | -50.00% |
| 40 | -60.00% | $400.00 | -60.00% |
| 30 | -70.00% | $300.00 | -70.00% |
| 20 | -80.00% | $200.00 | -80.00% |
| 10 | -90.00% | $100.00 | -90.00% |
| 0 | -100.00% | $0.00 | -100.00% |
*The underlyings exclude cash dividend payments on stocks included in the underlyings.
(1) Assumes a participation rate of 265%, the bottom of the specified range.
(2) The “Return on Securities” is the number, expressed as a percentage, which results from comparing the maturity payment amount per $1,000 face amount of securities to the purchase price of $1,000 per security.
(3) The hypothetical starting level of each
underlying.
2
How the maturity payment amount is calculated
If the ending level of the lowest performing underlying is greater than its starting level:
$1,000 + [$1,000 × underlying return of lowest performing underlying × participation rate]
If the ending level of the lowest performing underlying is less than or equal to its starting level, but greater than or equal to its threshold level:
the face amount of $1,000
If the ending level of the lowest performing underlying is less than its threshold level:
$1,000 + [$1,000 × underlying return of lowest performing underlying]
If the ending level of the lowest performing underlying is less than its threshold level, you will lose more than 25%, and possibly all, of the face amount of your securities at maturity.
Notwithstanding anything to the contrary in the accompanying
product supplement for PLUS, the amount you will receive at maturity will be the maturity payment amount, defined and calculated as provided
herein and in the accompanying preliminary terms.
3
Selected risk considerations
The risks set forth below are discussed in more detail in the “Risk Factors” section in the accompanying preliminary terms, product supplement for PLUS, index supplement and prospectus. Please review those risk factors carefully.
Risks Relating to an Investment in the Securities
| · | The securities do not pay interest, and you will lose more than 25%, and possibly all, of the face amount of your securities at maturity if the ending level of the lowest performing underlying is less than its respective threshold level. |
| · | The market price will be influenced by many unpredictable factors. |
| · | The securities are subject to our credit risk, and any actual or anticipated changes to our credit ratings or credit spreads may adversely affect the market value of the securities. |
| · | As a finance subsidiary, MSFL has no independent operations and will have no independent assets. |
| · | The amount payable on the securities is not linked to the values of the underlyings at any time other than the calculation day. |
| · | Investing in the securities is not equivalent to investing in either underlying. |
| · | The rate we are willing to pay for securities of this type, maturity and issuance size is likely to be lower than the rate implied by our secondary market credit spreads and advantageous to us. Both the lower rate and the inclusion of costs associated with issuing, selling, structuring and hedging the securities in the face amount reduce the economic terms of the securities, cause the estimated value of the securities to be less than the face amount and will adversely affect secondary market prices. |
| · | The estimated value of the securities is determined by reference to our pricing and valuation models, which may differ from those of other dealers and is not a maximum or minimum secondary market price. |
| · | The securities will not be listed on any securities exchange and secondary trading may be limited. |
| · | The calculation agent, which is a subsidiary of Morgan Stanley and an affiliate of MSFL, will make determinations with respect to the securities. |
| · | Hedging and trading activity by our affiliates could potentially adversely affect the value of the securities. |
| · | The maturity date may be postponed if the calculation day is postponed. |
| · | Potentially inconsistent research, opinions or recommendations by Morgan Stanley, MSFL, WFS or our or their respective affiliates. |
| · | The U.S. federal income tax consequences of an investment in the securities are uncertain. |
Risks Relating to the Underlyings
| · | You are exposed to the price risk of both underlyings. |
| · | Because the securities are linked to the performance of the lowest performing underlying, you are exposed to greater risk of sustaining a significant loss on your investment than if the securities were linked to just one underlying. |
| · | There are risks associated with investments in securities linked to the value of foreign equity securities. |
| · | Adjustments to the underlyings could adversely affect the value of the securities. |
| · | Historical levels of the underlyings should not be taken as an indication of the future performance of the underlyings during the term of the securities. |
For more information about the underlyings, including historical performance information, see the accompanying preliminary terms.
Not suitable for all investors
Investment suitability must be determined individually for each investor. The securities described herein are not a suitable investment for all investors. In particular, no investor should purchase the securities unless they understand and are able to bear the associated market, liquidity and yield risks. Unless market conditions and other relevant factors change significantly in your favor, a sale of the securities prior to maturity is likely to result in sale proceeds that are substantially less than the face amount per security. MS & Co., Wells Fargo Securities, LLC and our respective affiliates are not obligated to purchase the securities from you at any time prior to maturity.
Morgan Stanley and MSFL have filed a registration statement (including a prospectus, as supplemented by the applicable product supplement and the index supplement) with the Securities and Exchange Commission, or SEC, for the offering to which this communication relates. You should read the prospectus in that registration statement, the applicable product supplement, the index supplement and any other documents relating to this offering that Morgan Stanley and MSFL have filed with the SEC for more complete information about Morgan Stanley, MSFL and this offering. You may get these documents without cost by visiting EDGAR on the SEC web site at.www.sec.gov. Alternatively, Morgan Stanley, MSFL, any underwriter or any dealer participating in the offering will arrange to send you the applicable product supplement, index supplement and prospectus if you so request by calling toll-free 1-(800)-584-6837.
Consult your tax advisor
Investors should review carefully the accompanying preliminary terms, product supplement for PLUS, index supplement, prospectus supplement and prospectus and consult their tax advisors regarding the application of the U.S. federal income tax laws to their particular circumstances, as well as any tax consequences arising under the laws of any state, local or foreign jurisdiction.
“EURO STOXX 50®” and “STOXX®” are registered trademarks of STOXX Limited.
“STOXX® Europe 600” and “STOXX®” are registered trademarks of STOXX Limited.
Wells Fargo Advisors is a trade name used by Wells Fargo Clearing Services, LLC and Wells Fargo Advisors Financial Network, LLC, members SIPC, separate registered broker-dealers and non-bank affiliates of Wells Fargo Finance LLC and Wells Fargo & Company.
4
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley Comments on Moderna (MRNA) Collaboration with OpenAI
- Xiaomi's 2024 investor day will boost confidence - Morgan Stanley
- Morgan Stanley Re-explains it's $310 Price Target on Tesla (TSLA)
Create E-mail Alert Related Categories
SEC FilingsRelated Entities
Morgan StanleySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
